Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1954 1
1956 1
1957 2
1958 1
1959 1
1960 1
1961 3
1969 1
1970 1
1972 4
1973 3
1975 3
1976 4
1978 4
1979 4
1980 7
1981 4
1982 5
1983 7
1984 3
1985 7
1986 8
1987 11
1988 11
1989 11
1990 6
1991 7
1992 7
1993 7
1994 13
1995 15
1996 12
1997 15
1998 5
1999 13
2000 9
2001 6
2002 8
2003 6
2004 9
2005 9
2006 10
2007 17
2008 16
2009 11
2010 8
2011 12
2012 8
2013 5
2014 10
2015 9
2016 11
2017 5
2018 9
2019 9
2020 12
2021 11
2022 16
2023 12
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

423 results

Results by year

Filters applied: . Clear all
Page 1
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kaźmierczak M, Lamanna N, O'Brien SM, Tam CS, Qiu L, Zhou K, Simkovic M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Osterborg A, Yimer HA, Salmi T, Wang MD, Fu L, Li J, Wu K, Cohen A, Shadman M. Brown JR, et al. Among authors: salmi t. N Engl J Med. 2023 Jan 26;388(4):319-332. doi: 10.1056/NEJMoa2211582. Epub 2022 Dec 13. N Engl J Med. 2023. PMID: 36511784 Clinical Trial.
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.
Hillmen P, Eichhorst B, Brown JR, Lamanna N, O'Brien SM, Tam CS, Qiu L, Kazmierczak M, Zhou K, Šimkovič M, Mayer J, Gillespie-Twardy A, Shadman M, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Österborg A, Yimer HA, Salmi T, Ji M, Yecies J, Idoine A, Wu K, Huang J, Jurczak W. Hillmen P, et al. Among authors: salmi t. J Clin Oncol. 2023 Feb 10;41(5):1035-1045. doi: 10.1200/JCO.22.00510. Epub 2022 Nov 17. J Clin Oncol. 2023. PMID: 36395435 Free PMC article. Clinical Trial.
Dermatitis herpetiformis.
Salmi TT. Salmi TT. Clin Exp Dermatol. 2019 Oct;44(7):728-731. doi: 10.1111/ced.13992. Epub 2019 May 15. Clin Exp Dermatol. 2019. PMID: 31093998 Review.
Microwave-Assisted Conversion of Carbohydrates.
Kustov LM, Kustov AL, Salmi T. Kustov LM, et al. Among authors: salmi t. Molecules. 2022 Feb 22;27(5):1472. doi: 10.3390/molecules27051472. Molecules. 2022. PMID: 35268573 Free PMC article. Review.
Current Concepts of Dermatitis Herpetiformis.
Salmi T, Hervonen K. Salmi T, et al. Acta Derm Venereol. 2020 Feb 12;100(5):adv00056. doi: 10.2340/00015555-3401. Acta Derm Venereol. 2020. PMID: 32039457 Free PMC article. Review.
Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease.
Watt KI, Henstridge DC, Ziemann M, Sim CB, Montgomery MK, Samocha-Bonet D, Parker BL, Dodd GT, Bond ST, Salmi TM, Lee RS, Thomson RE, Hagg A, Davey JR, Qian H, Koopman R, El-Osta A, Greenfield JR, Watt MJ, Febbraio MA, Drew BG, Cox AG, Porrello ER, Harvey KF, Gregorevic P. Watt KI, et al. Among authors: salmi tm. Nat Commun. 2021 May 17;12(1):2887. doi: 10.1038/s41467-021-23240-7. Nat Commun. 2021. PMID: 34001905 Free PMC article.
423 results